MedPath

INFLUVAC TETRA

INFLUVAC TETRA

Approved
DIN Number

02484854

Drug Class

Human

Market Date

Oct 17, 2019

Company
HC

BGP Pharma ULC

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02484854
AIG Number0455410003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular ,  Subcutaneous
AHFS Classification80:12.00
Health Canada Classification

ACTIVE INGREDIENTS (4)

HAEMAGGLUTININ-STRAIN A (H1N1)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H1N1)
HAEMAGGLUTININ-STRAIN A (H3N2)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN A (H3N2)
HAEMAGGLUTININ-STRAIN B (VICTORIA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (VICTORIA)
HAEMAGGLUTININ-STRAIN B (YAMAGATA)Active
Strength: 15 MCG / 0.5 ML
Monograph: HAEMAGGLUTININ-STRAIN B (YAMAGATA)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.